Skip to main content
Explore URMC

menu

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Research Question:
Does the drug bardoxolone help patients with connective tissue disease walk better?

Basic Study Information

Purpose:
This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with connective tissue disease-associated pulmonary arterial hypertension to determine the recommended dose range and evaluate the change from baseline in 6-minute walk distance (6MWD) following 24 weeks of study participation.

Location: University of Rochester - University of Rochester Medical Center

Study Contact Information

Study Coordinator: Research Coordinator
Phone: (585) 486-0869

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search